Like any 3D printing material, graphene isn’t perfect; it can be carcinogenic if the particles are inhaled, for example, and more research is needed into how to optimally 3D print it. The material is about to be the subject of a new research study conducted by the Herston Biofabrication Institute at the Queensland University of Technology. The researchers plan to investigate the use of graphene for biomedical treatments.
The graphene used in the study will be provided by Graphene Manufacturing Group, a Brisbane, Australia-based company that is currently one of the world’s leading manufacturers of graphene in bulk.
“We will be providing the Institute with a range of different graphene platelet sizes and shapes to assist with essential research into personalised vascular surgery prognosis, training, and treatment,” said Craig Nicol, Founder and Managing Director of Graphene Manufacturing Group. “GMG has expertise in dispersing graphene effectively into polymer and other materials and we will be advising and mentoring the process of adapting graphene dispersions for 3D printing.”
Graphene Manufacturing Groups’ goals include making graphene accessible for everyday products for applications that were previously not possible due to the high costs of manufacturing the material. The company’s proprietary process creates a continuous, bulk supply of graphene at a much lower cost that existing production methods.
The $54 million Herston Biofabrication Institute was recently established at Herston Health Precinct, which is adjacent to Royal Brisbane and Women’s Hospital. The Institute will be collaborating with Graphene Manufacturing Group as well as surgeons, academics and other industry partners to develop 3D platform technologies such as scanning, modeling and printing in three major areas of healthcare: personalized orthopedics, burn injury treatment and vascular surgery. The project is being co-led by Dr. Jenkins, head of surgical services at Metro North Health.
“Graphene is 200 times stronger than steel, 1,000 times more conductive than copper, heat resistant to 3,500 degrees Celsius and has implications for virtually every industry that comes to mind,” Nicol said. “Our technology allows us to produce high-quality graphene nano-platelets more affordably than any competitor globally, making it perfect for medical trials and health-based research such as the Herston Biofabrication Institute work. We expect to see our graphene lead to true health-based innovation delivering significant and long-lasting health benefits through the creation of stronger and more effective stents with potential antibacterial properties, cell culture biocompatibility and enhanced mechanics.”
The State Government is supporting the work of 30 researchers through $7.2 million worth of Advance Queensland Industry Research Fellowships.
Discuss this and other 3D printing topics at 3DPrintBoard.com or share your thoughts below.
You May Also Like
Researchers Create Smart Composite Material from Graphene Oxide and Seaweed-Derived Alginate
Usually when I think about seaweed, I’m trying to decide which particular sushi roll to order at dinner. But a team of researchers from Brown University in Rhode Island, which...
3D Printing News Briefs: December 30, 2018
In this week’s abbreviated 3D Printing News Briefs, we’ve got a story on a new type of 3D printing that makes it easy to 3D print small objects, and a...
Researchers Create Bionic Mushroom with Graphene and 3D Printed Cyanobacteria
Using 3D printing, researchers at Stevens Institute of Technology have created a bionic mushroom. Why? For good reason, actually. The researchers are working to better understand the biological machinery of cells...
Electrically Conductive PEEK Composites for FDM 3D Printing
Fused deposition modeling (FDM) is a 3D printing method that can easily meet the requirements for small series industrial manufacturing. However, there aren’t a lot of commercially available materials that...
View our broad assortment of in house and third party products.